Annual EBITDA
-$239.46 M
+$4.78 M+1.96%
31 December 2023
Summary:
REGENXBIO annual earnings before interest, taxes, depreciation & amortization is currently -$239.46 million, with the most recent change of +$4.78 million (+1.96%) on 31 December 2023. During the last 3 years, it has fallen by -$142.63 million (-147.30%). RGNX annual EBITDA is now -235.22% below its all-time high of $177.09 million, reached on 31 December 2021.RGNX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$54.82 M
-$6.33 M-13.05%
30 September 2024
Summary:
REGENXBIO quarterly earnings before interest, taxes, depreciation & amortization is currently -$54.82 million, with the most recent change of -$6.33 million (-13.05%) on 30 September 2024. Over the past year, it has increased by +$1.06 million (+1.89%). RGNX quarterly EBITDA is now -117.32% below its all-time high of $316.53 million, reached on 31 December 2021.RGNX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$217.82 M
+$1.06 M+0.48%
30 September 2024
Summary:
REGENXBIO TTM earnings before interest, taxes, depreciation & amortization is currently -$217.82 million, with the most recent change of +$1.06 million (+0.48%) on 30 September 2024. Over the past year, it has increased by +$15.84 million (+6.78%). RGNX TTM EBITDA is now -223.00% below its all-time high of $177.09 million, reached on 31 December 2021.RGNX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGNX EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.0% | +1.9% | +6.8% |
| 3 y3 years | -147.3% | -12.2% | -23.0% |
| 5 y5 years | -321.5% | -61.1% | -160.3% |
RGNX EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -235.2% | +2.0% | -117.3% | +19.4% | -223.0% | +10.8% |
| 5 y | 5 years | -235.2% | +2.0% | -117.3% | +19.4% | -223.0% | +10.8% |
| alltime | all time | -235.2% | +2.0% | -117.3% | +19.4% | -223.0% | +10.8% |
REGENXBIO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$54.82 M(+13.0%) | -$217.82 M(-0.5%) |
| June 2024 | - | -$48.49 M(-15.2%) | -$218.88 M(-7.6%) |
| Mar 2024 | - | -$57.18 M(-0.3%) | -$236.90 M(-1.1%) |
| Dec 2023 | -$239.46 M(-2.0%) | -$57.34 M(+2.6%) | -$239.46 M(+2.5%) |
| Sept 2023 | - | -$55.87 M(-16.0%) | -$233.66 M(-4.1%) |
| June 2023 | - | -$66.51 M(+11.3%) | -$243.77 M(+3.3%) |
| Mar 2023 | - | -$59.74 M(+15.9%) | -$235.94 M(-3.4%) |
| Dec 2022 | -$244.24 M(-237.9%) | -$51.54 M(-21.9%) | -$244.24 M(-297.2%) |
| Sept 2022 | - | -$65.98 M(+12.4%) | $123.83 M(-12.1%) |
| June 2022 | - | -$58.68 M(-13.8%) | $140.94 M(-6.4%) |
| Mar 2022 | - | -$68.04 M(-121.5%) | $150.55 M(-15.0%) |
| Dec 2021 | $177.09 M(-282.9%) | $316.53 M(-747.7%) | $177.09 M(-200.0%) |
| Sept 2021 | - | -$48.87 M(-0.4%) | -$177.07 M(+51.0%) |
| June 2021 | - | -$49.07 M(+18.2%) | -$117.23 M(+16.9%) |
| Mar 2021 | - | -$41.50 M(+10.3%) | -$100.29 M(+3.6%) |
| Dec 2020 | -$96.83 M(+7.2%) | -$37.62 M(-443.1%) | -$96.83 M(+110.0%) |
| Sept 2020 | - | $10.96 M(-134.1%) | -$46.10 M(-49.4%) |
| June 2020 | - | -$32.13 M(-15.5%) | -$91.09 M(-3.2%) |
| Mar 2020 | - | -$38.04 M(-390.2%) | -$94.09 M(+4.2%) |
| Dec 2019 | -$90.34 M | $13.11 M(-138.5%) | -$90.34 M(+8.0%) |
| Sept 2019 | - | -$34.03 M(-3.1%) | -$83.67 M(+17.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$35.12 M(+2.4%) | -$71.42 M(+145.8%) |
| Mar 2019 | - | -$34.29 M(-273.4%) | -$29.05 M(-126.9%) |
| Dec 2018 | $108.10 M(-247.7%) | $19.78 M(-190.8%) | $108.10 M(+49.2%) |
| Sept 2018 | - | -$21.78 M(-400.6%) | $72.45 M(-1.6%) |
| June 2018 | - | $7.25 M(-93.0%) | $73.63 M(+41.5%) |
| Mar 2018 | - | $102.86 M(-747.9%) | $52.03 M(-171.1%) |
| Dec 2017 | -$73.20 M(+13.0%) | -$15.88 M(-22.9%) | -$73.20 M(-5.6%) |
| Sept 2017 | - | -$20.60 M(+43.5%) | -$77.51 M(+2.8%) |
| June 2017 | - | -$14.35 M(-35.8%) | -$75.42 M(-0.7%) |
| Mar 2017 | - | -$22.37 M(+10.8%) | -$75.96 M(+17.2%) |
| Dec 2016 | -$64.80 M(+185.3%) | -$20.19 M(+9.1%) | -$64.80 M(+30.3%) |
| Sept 2016 | - | -$18.51 M(+24.2%) | -$49.75 M(+29.0%) |
| June 2016 | - | -$14.90 M(+33.0%) | -$38.56 M(+28.8%) |
| Mar 2016 | - | -$11.20 M(+118.0%) | -$29.94 M(+31.7%) |
| Dec 2015 | -$22.71 M(+516.8%) | -$5.14 M(-29.8%) | -$22.72 M(+14.8%) |
| Sept 2015 | - | -$7.32 M(+16.6%) | -$19.80 M(+39.6%) |
| June 2015 | - | -$6.28 M(+57.2%) | -$14.18 M(+79.3%) |
| Mar 2015 | - | -$3.99 M(+80.0%) | -$7.91 M(+101.9%) |
| Dec 2014 | -$3.68 M(-22.9%) | -$2.22 M(+30.3%) | -$3.92 M(+130.3%) |
| Sept 2014 | - | -$1.70 M | -$1.70 M |
| Dec 2013 | -$4.78 M | - | - |
FAQ
- What is REGENXBIO annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for REGENXBIO?
- What is REGENXBIO annual EBITDA year-on-year change?
- What is REGENXBIO quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for REGENXBIO?
- What is REGENXBIO quarterly EBITDA year-on-year change?
- What is REGENXBIO TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for REGENXBIO?
- What is REGENXBIO TTM EBITDA year-on-year change?
What is REGENXBIO annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of RGNX is -$239.46 M
What is the all time high annual EBITDA for REGENXBIO?
REGENXBIO all-time high annual earnings before interest, taxes, depreciation & amortization is $177.09 M
What is REGENXBIO annual EBITDA year-on-year change?
Over the past year, RGNX annual earnings before interest, taxes, depreciation & amortization has changed by +$4.78 M (+1.96%)
What is REGENXBIO quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of RGNX is -$54.82 M
What is the all time high quarterly EBITDA for REGENXBIO?
REGENXBIO all-time high quarterly earnings before interest, taxes, depreciation & amortization is $316.53 M
What is REGENXBIO quarterly EBITDA year-on-year change?
Over the past year, RGNX quarterly earnings before interest, taxes, depreciation & amortization has changed by +$1.06 M (+1.89%)
What is REGENXBIO TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of RGNX is -$217.82 M
What is the all time high TTM EBITDA for REGENXBIO?
REGENXBIO all-time high TTM earnings before interest, taxes, depreciation & amortization is $177.09 M
What is REGENXBIO TTM EBITDA year-on-year change?
Over the past year, RGNX TTM earnings before interest, taxes, depreciation & amortization has changed by +$15.84 M (+6.78%)